Global specialty pharmaceutical company supports Dream Foundation’s work to provide comfort, closure, and inspiration at the end of life. BEDMINSTER, N.J. and SANTA BARBARA, Calif., May 30, 2023 /PRNewswire/ — Kyowa Kirin, Inc., an affiliate of Kyowa Kirin. Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company, has extended its support of Dream Foundation – … Read more
DUBLIN, May 30, 2023 /PRNewswire/ — The “Global Cell-Based Assay Market – A Global and Regional Analysis: Focus on Product, Services, Application, End User, Technology, Regional Analysis, and Competitive Landscape – Analysis and Forecast, 2023-2032” report has been added to ResearchAndMarkets.com’s offering. The global cell-based assay market is expected to reach $38.23 billion in 2032 from … Read more
MUMBAI, India and SIENA, Italy, May 30, 2023 /PRNewswire/ — Sun Pharmaceutical Industries Limited (Reuters: SUN.BO), (Bloomberg: SUNP IN), (NSE: SUNPHARMA), (BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Philogen S.p.A (BIT: PHIL) today announced that they have entered into a licensing agreement for commercializing Philogen’s specialty product, Nidlegy™ (Daromun) in … Read more
PUNE, India, May 30, 2023 /PRNewswire/ — According to a recent market study published by Growth Market Reports, titled, “Metformin Hydrochloride Market Segments – By Type (Metformin Hydrochloride-Immediate Release, Metformin Hydrochloride-Extended Release), By Distribution Channel (Hospital Pharmacy, Drug Store, Retail Pharmacy, Online Pharmacy), and Region: Size, Share, Trends and Opportunity Analysis, 2023-2031“, the market size was USD … Read more
TAMPA, Fla., 30 de mayo de 2023 /PRNewswire/ — El 24 de mayo de 2023, la FDA de EE.UU. otorgó una exención de dispositivo de investigación (IDE) para el balón recubierto de sirolimus (SCB) MagicTouch PTA de Concept Medical Inc para el tratamiento de las arterias femorales superficiales (SFA). Esto marca la cuarta aprobación de IDE para el balón … Read more
LONDON, May 29, 2023 /PRNewswire/ — Pains or aches can be a resultant of injuries, diseases, muscle or bone related issues, among others. Frequent aches disrupt our quality of life and prevents us from doing several things. Pain relief therapeutics have played a significant role in improving the quality of life for countless individuals worldwide. … Read more
TAMPA, Fla., May 29, 2023 /PRNewswire/ — The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s Sirolimus Coated Balloon (SCB) MagicTouch PTA for the treatment of Superficial Femoral Arteries (SFA). This marks the fourth IDE approval for the Company’s Sirolimus coated balloon. The Company has … Read more
SAN DIEGO, May 29, 2023 /PRNewswire/ — Amplo Biotechnology, a leading US-based biotech company dedicated to developing innovative AAV-based gene therapies for neuromuscular junction disorders announced the award of a Fast Track Phase I/II STTR grant from the NIH-NIAMS. This highly competitive grant will provide substantial funding for the advancement of AMP-201, an AAV-ColQ gene … Read more
OSAKA, Japan, May 29, 2023 /PRNewswire/ — RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting. Their presentation demonstrated that in a murine pemphigus model, S/F-iTregs significantly decreased clinical scores, circulating anti-Dsg3 IgG titers, and other autoimmune markers related to Pemphigus. Collaborators also reported that S/F-iTregs generated … Read more
Porustobart in combination of toripalimab showed promising anti-tumor activity Porustobart in combination of toripalimab showed acceptable safety profile in HCC Porustobart in combination of toripalimab showed favorable PK/PD signature CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, May 28, 2023 /PRNewswire/ — Harbour BioMed (the “Company”, HKEX: 02142), a global biopharmaceutical company committed to the discovery, … Read more